CGS vs NYR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

58MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

CGS NYR
Technical
47
47
Catalyst
53
49
Sentiment
50
50
Fundamental
96
46
Momentum
79
67
Risk Gate
50
42

Key Metrics

CGS Metric NYR
$489.3MMarket Cap$101.3M
397KAvg Volume (20d)185K
+0.1%Short InterestN/A
$3.01052-Week High$1.435
$1.55052-Week Low$0.225
-3.5%Daily Change-2.4%
$2.780Reference Price$0.400
+22.5%ROE-71.0%
+19.2%Profit Margin-234.3%

Active Signals

CGS Signals

●MACD crossed bearish — momentum is fading
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.7x)
●Moderate revenue growth (+12%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

NYR Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 4.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare CGS and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CMP vs EMD →CMP vs EPN →CMP vs LDX →CMP vs MAP →CMP vs MVP →
CGS Full Analysis → NYR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).